Tag » Branford

CT Innovations Adds to Branford Pharma Investment

Branford’s New Haven Pharmaceuticals, a CAPCO Program company, has raised more money:

Branford’s New Haven Pharmaceuticals has raised $1.6 million from several investors, including Connecticut Innovations, which announced the deal.

The company will use the funds to help it advance its first drug product, Durlaza, which is meant to be a secondary prevention for strokes and acute cardiovascular events.

Read more »